Inspire Medical Systems Inc - Asset Resilience Ratio
Inspire Medical Systems Inc (INSP) has an Asset Resilience Ratio of 20.83% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Inspire Medical Systems Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2025)
This chart shows how Inspire Medical Systems Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see INSP total assets.
Liquid Assets Composition Over Time
This chart breaks down Inspire Medical Systems Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore investment intensity of Inspire Medical Systems Inc to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $192.92 Million | 20.83% |
| Total Liquid Assets | $192.92 Million | 20.83% |
Asset Resilience Insights
- Good Liquidity Position: Inspire Medical Systems Inc maintains a healthy 20.83% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Inspire Medical Systems Inc Industry Peers by Asset Resilience Ratio
Compare Inspire Medical Systems Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Eurobio Scientific SA
PA:ALERS |
Medical Devices | 10.52% |
|
Profound Medical Corp
TO:PRN |
Medical Devices | 67.66% |
|
EBR Systems Inc
AU:EBR |
Medical Devices | 54.70% |
|
Epitomee Medical Ltd
TA:EPIT |
Medical Devices | 0.24% |
|
Cleo Diagnostics Ltd
AU:COV |
Medical Devices | 94.64% |
|
Aligned Genetics Inc
KQ:238120 |
Medical Devices | 2.22% |
Annual Asset Resilience Ratio for Inspire Medical Systems Inc (2016–2025)
The table below shows the annual Asset Resilience Ratio data for Inspire Medical Systems Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 22.42% | $203.46 Million | $907.32 Million | -14.12pp |
| 2024-12-31 | 36.54% | $295.40 Million | $808.38 Million | -4.07pp |
| 2023-12-31 | 40.61% | $274.84 Million | $676.81 Million | +38.87pp |
| 2022-12-31 | 1.74% | $9.82 Million | $564.88 Million | -- |
| 2021-12-31 | 0.00% | $0.00 | $295.08 Million | -- |
| 2020-12-31 | 15.59% | $43.84 Million | $281.19 Million | -54.26pp |
| 2019-12-31 | 69.85% | $126.61 Million | $181.25 Million | +24.41pp |
| 2018-12-31 | 45.44% | $90.92 Million | $200.08 Million | +16.80pp |
| 2017-12-31 | 28.65% | $7.19 Million | $25.09 Million | -- |
| 2016-12-31 | 0.00% | $0.00 | $13.12 Million | -- |
About Inspire Medical Systems Inc
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develop… Read more